reflexmd tirzepatide Review: How the Program Prescribes – PlexusDx Tirzepatide Unlikely to Exacerbate DR
Description
Research shows that approximately 30 to 40 percent of patients on GLP-1 medications experience weight loss plateaus within 6 to 12 months
In clinical trials, patients taking the Wegovy pill (oral semaglutide) lost an average of 16.6% of their starting body weight over 64 weeks
JCI Insight 7 , (2022)
Our facilities are conveniently located across Las Vegas, making it easy for you to attend appointments and stay engaged with your program
